BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, May 16, 2024
Breaking News: Try BioWorld for free for two weeks
See today's BioWorld Science
Home
» Tentarix brings Tentacles platform to Abbvie collaboration in oncology and immunology
To read the full story,
subscribe
or
sign in
.
Immuno-oncology
Tentarix brings Tentacles platform to Abbvie collaboration in oncology and immunology
Feb. 23, 2024
No Comments
Abbvie Inc. and Tentarix Biotherapeutics Inc. have established a multiyear collaboration focused on the discovery and development of conditionally active, multispecific biologic candidates against one target in oncology and another in immunology.
BioWorld Science
Collaboration
Cancer
Immune
Immuno-oncology